Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy

19 March 2022 (13:36 - 13:43)
Organised by:
Congress Presentation Part of: Cardiac arrest, rhythm and other Clinical ACVC Premium Access ESC Acute CardioVascular Care 2022

ESC 365 is supported by

ESC 365 is supported by